Medical Science Liaison

Liège - Belgium

Monthly Salary: Not Disclosed

Posted on: 8 hours ago

Vacancies: 1 Vacancy

Job Summary

Core responsibilities

Scientific exchange with HCPs and experts:

Engage in peertopeer compliant scientific discussions with KOLs and HCPs (e.g. allergists ENT pulmonologists pediatricians GPs) on disease state clinical evidence guidelines and appropriate use of ALK therapies.
Deliver nonpromotional scientific presentations (1:1 and group) at meetings clinical sessions and educational events.
Support scientific advisory boards and educational initiatives to inform clinical evidence needs and advance best practice in patient care.
Systematically capture synthesize and share field insights (HCPs reimbursement stakeholders hospital committees)
Use approved materials; document field interactions and insights in approved systems (Veeva).
Monitor and communicate scientific developments competitor clinical evidence and guideline updates relevant to ALKs therapeutic areas.

Market access stakeholder engagement (nonpromotional):

Map and cultivate scientific relationships with reimbursement and access stakeholders including INAMI/RIZIV mutualities/sickness funds and hospital formulary/P&T committees; engage competent authorities (e.g. AFMPS) for scientific exchange as appropriate in line with Medical governance and local codes.
Communicate unbiased evidencebased clinical value messages derived from the Global/Local Value Dossier tailored to the needs of payer and access stakeholders.
Respond to scientific queries from reimbursement stakeholders and coordinate timely compliant followup with internal Medical and Market Access colleagues.

Value dossier and scientific support:

Contribute to the local adaptation of the Global Value Dossier for Belgium: ensure the clinical narrative comparators endpoints epidemiology and care pathways reflect local practice and expectations.
Curate review and align local clinical literature and guideline updates to support value messaging and access materials under Medical governance.
Support development of scientific briefing documents and FAQs for use in compliant engagements with access stakeholders; ensure consistency and accuracy across materials.

Education: Advanced degree in life sciences (PhD MD PharmD MSc) required.

Experience: Prior MSL/Medical Affairs experience in pharma/biotech strongly preferred; experience engaging with reimbursement stakeholders in Belgium is a plus.

Scientific/clinical: Strong ability to interpret and communicate clinical evidence; familiarity with immunology/allergy/respiratory is advantageous.

Communication: Excellent scientific communication and presentation skills; ability to translate complex clinical evidence into clear balanced stakeholderappropriate scientific messages.

Project management: Proven ability to manage crossfunctional projects with multiple stakeholders and timelines.

Languages: Fluency in French and English required; proficiency in Dutch preferred (role is Walloniafocused but national stakeholder interactions often require Dutch/English).

Other: Valid drivers license; willingness to travel 6070% within Wallonia and to Brussels for national engagements.

Location: Belgium (field-based Wallonia; regular travel to Brussels for national stakeholders)

Core responsibilitiesScientific exchange with HCPs and experts:Engage in peertopeer compliant scientific discussions with KOLs and HCPs (e.g. allergists ENT pulmonologists pediatricians GPs) on disease state clinical evidence guidelines and appropriate use of ALK therapies.Deliver nonpromotional sci...

Core responsibilities

Scientific exchange with HCPs and experts:

Engage in peertopeer compliant scientific discussions with KOLs and HCPs (e.g. allergists ENT pulmonologists pediatricians GPs) on disease state clinical evidence guidelines and appropriate use of ALK therapies.
Deliver nonpromotional scientific presentations (1:1 and group) at meetings clinical sessions and educational events.
Support scientific advisory boards and educational initiatives to inform clinical evidence needs and advance best practice in patient care.
Systematically capture synthesize and share field insights (HCPs reimbursement stakeholders hospital committees)
Use approved materials; document field interactions and insights in approved systems (Veeva).
Monitor and communicate scientific developments competitor clinical evidence and guideline updates relevant to ALKs therapeutic areas.

Market access stakeholder engagement (nonpromotional):

Map and cultivate scientific relationships with reimbursement and access stakeholders including INAMI/RIZIV mutualities/sickness funds and hospital formulary/P&T committees; engage competent authorities (e.g. AFMPS) for scientific exchange as appropriate in line with Medical governance and local codes.
Communicate unbiased evidencebased clinical value messages derived from the Global/Local Value Dossier tailored to the needs of payer and access stakeholders.
Respond to scientific queries from reimbursement stakeholders and coordinate timely compliant followup with internal Medical and Market Access colleagues.

Value dossier and scientific support:

Contribute to the local adaptation of the Global Value Dossier for Belgium: ensure the clinical narrative comparators endpoints epidemiology and care pathways reflect local practice and expectations.
Curate review and align local clinical literature and guideline updates to support value messaging and access materials under Medical governance.
Support development of scientific briefing documents and FAQs for use in compliant engagements with access stakeholders; ensure consistency and accuracy across materials.